You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 5, May 1942 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

HISTOLOGIC EVALUATION OF THE EFFECTS OF ICHTHAMMOL

C. D. STEWART, M.D.; MILTON GOLDMAN, M.D.; MAXIMILIAN E. OBERMAYER, M.D.

Arch Derm Syphilol. 1942;45(5):933-940.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Ichthammol is a sulfonated bitumen of complex structure. As early as 1883 Baumann and Schotten,1 after purely chemical research, drew up an empiric formula for a sulfone compound, ammonium ichthosulfonate, which they called ichthyol (sulfonated bitumen N. F. V; ichthammol N. F. VI). Three years later Unna2 published the first comprehensive study on its clinical application. He recommended the compound primarily for the therapy of dermatoses, but he also mentioned that it was useful when administered internally for treating gout and rheumatic conditions. It was first used in gynecologic practice by Freund3 in 1890. Shortly thereafter Neisser4 and Jadassohn5 recommended it for the treatment of gonorrhea. More recently Scheibler6 and Scheibler and Rettig7 showed that its therapeutic effect is due to its sulfur-containing compounds, principally thiophene homologues. In 1931 Pincussen8 stated that one action of the substance is to effect a change . . . [Full Text PDF of this Article]


Author Affiliations

CORPUS CHRISTI, TEXAS; LOS ANGELES

From the Section of Dermatology, University of Chicago, the School of Medicine.


Footnotes

This study was supported by a grant from Merck & Co., Inc.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1942 American Medical Association. All Rights Reserved.